<p>Diagnostic performances of 4 biomarkers for each biomarker and for every combination using 2–4 biomarkers for HCC diagnosis with LC control in subgroup showing a low AFP level (<20 ng/mL).</p
<p><b>(A)</b> Serum GDF15 levels in two HCC groups with AFP ≤20 ng/mL (n = 91) and >20 ng/mL (n = 13...
<p>Mean MDK, OPN, DKK1 and AFP levels in HCC patients according to various clinical parameters.</p
The purpose of this study was to evaluate the diagnostic efficiency for hepatocellular carcinoma (HC...
<p>Diagnostic performances of 4 biomarkers for each biomarker and for every combination using 2–4 bi...
<p>(Top) Representative H&E-stained livers sections (20 X) from a Kcnn4/ KCa3.1 null mice mouse on a...
<p>(A and B) ROC curve of DCP in AFP-negative HCC versus all control subjects (HCs and DC). (C and D...
<p>(A) Dynamic changes of AFP-L3% in each HCC patient. The results of the assay showed that AFP-L3% ...
<p>(A and B) The concentrations of serum DCP in HCC according to tumor size (<3cm, ≥3 and ≤5cm, >5 a...
<p>*Note: AFP: a-fetoprotein; CHE: serum cholinesterase.</p><p>Comparison of clinical parameters of ...
AbstractBackground Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of sc...
The role of α-fetoprotein (AFP) in the surveillance and diagnosis of hepatocellular carcinoma (HCC) ...
<p>Diagnostic performance of miRNA panels in combination with alpha-fetoprotein in differentiating H...
<p>Performance of the biomarkers listed in <a href="http://www.plosone.org/article/info:doi/10.1371/...
Sensitivity of AFP and the Doylestown algorithm at times before HCC diagnosis.</p
Background and Aim: Alpha-fetoprotein (AFP), a lens culinaris agglutinin-reactive fraction of AFP (A...
<p><b>(A)</b> Serum GDF15 levels in two HCC groups with AFP ≤20 ng/mL (n = 91) and >20 ng/mL (n = 13...
<p>Mean MDK, OPN, DKK1 and AFP levels in HCC patients according to various clinical parameters.</p
The purpose of this study was to evaluate the diagnostic efficiency for hepatocellular carcinoma (HC...
<p>Diagnostic performances of 4 biomarkers for each biomarker and for every combination using 2–4 bi...
<p>(Top) Representative H&E-stained livers sections (20 X) from a Kcnn4/ KCa3.1 null mice mouse on a...
<p>(A and B) ROC curve of DCP in AFP-negative HCC versus all control subjects (HCs and DC). (C and D...
<p>(A) Dynamic changes of AFP-L3% in each HCC patient. The results of the assay showed that AFP-L3% ...
<p>(A and B) The concentrations of serum DCP in HCC according to tumor size (<3cm, ≥3 and ≤5cm, >5 a...
<p>*Note: AFP: a-fetoprotein; CHE: serum cholinesterase.</p><p>Comparison of clinical parameters of ...
AbstractBackground Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of sc...
The role of α-fetoprotein (AFP) in the surveillance and diagnosis of hepatocellular carcinoma (HCC) ...
<p>Diagnostic performance of miRNA panels in combination with alpha-fetoprotein in differentiating H...
<p>Performance of the biomarkers listed in <a href="http://www.plosone.org/article/info:doi/10.1371/...
Sensitivity of AFP and the Doylestown algorithm at times before HCC diagnosis.</p
Background and Aim: Alpha-fetoprotein (AFP), a lens culinaris agglutinin-reactive fraction of AFP (A...
<p><b>(A)</b> Serum GDF15 levels in two HCC groups with AFP ≤20 ng/mL (n = 91) and >20 ng/mL (n = 13...
<p>Mean MDK, OPN, DKK1 and AFP levels in HCC patients according to various clinical parameters.</p
The purpose of this study was to evaluate the diagnostic efficiency for hepatocellular carcinoma (HC...